SuPPoRT: finding the best way to prevent preterm birth in women with short cervixes

Professor Andrew Shennan, Dr Rachel Tribe, Dr Natasha Hezelgrave, Helena Watson, Alexandra Ridout

Our researchers are comparing 3 different ways of treating a short cervix during pregnancy, to help stop babies being born too early.

Project ongoing

Why do we need this research?

The cervix is important in stopping a baby being born too early. During pregnancy, the cervix changes shape as the baby grows inside the womb. If it gets too short before the baby is due, there is a high risk of the baby being born prematurely. This can lead to health problems for the baby, and is a major cause of death shortly after birth. We need to find the best way to prevent premature birth.

What’s happening in this project?

If a woman’s cervix is less than 25mm long when she is under 23 weeks pregnant, it is too short and should be treated. At the moment, there are three treatments that can be used if this happens.

Some women have a small surgical procedure called cervical cerclage. This involves an operation to put a stitch around the cervix to try and help it stay closed, keeping the baby inside the womb.

Others are given progesterone, a natural hormone that is usually made in the ovary during the menstrual cycle. This is given vaginally using a suppository.

Finally, some women use a cervical pessary: a silicon device put in by a doctor that sits around the cervix to help it stay closed. Putting a pessary in doesn’t need an operation.

To date, these three ways of stopping premature birth haven’t been compared. SuPPoRT is a randomised control trial that aims to find out which of these three methods is best at preventing premature birth, or if they are as effective as each other.

As of October 2019, the team have recruited nearly 300 women, and hope to recruit around 400 in total from across England.

Take part in the SuPPoRT trial

What difference will this project make?

There are three methods to prevent premature labour in pregnant women with short cervixes. The SuPPoRT trial will find out whether any of these methods is better than the others. Ultimately this will help doctors and women decide on the best treatment to reduce the chances of giving birth too soon, and give them the best chance of having a healthy baby.

Get our research updates

Tommy's funds research across the UK investigating the reasons for pregnancy complications and loss. If you're interested in being kept updated about our research and news from Tommy's, click here.

More research projects

Read Tommy's news and views

  • A nurse taking a patients blood pressure in a hospital room

    News

    Pregnancy is a unique chance to predict health risks to mums

    A recently published article, co-authored by Professor Catherine Williamson from Tommy’s Research Centre at King’s College London, suggests that certain pregnancy complications can indicate future health issues for women.

  • Rising demand for Tommy's midwives in coronavirus lockdown

    News

    Tommy’s awarded grant to help meet rising demand for support during coronavirus lockdown

    Tommy’s has received a grant from the UK Government’s Department for Health and Social Care to support the costs of its PregnancyHub information and support services throughout the summer, due to rising demand in the wake of coronavirus.

  • Tommy's researchers latest findings

    News

    Tommy’s Research Centres continue vital work on pregnancy complications

    Although recruitment to some clinical trials had to be paused when coronavirus hit the UK, scientists at Tommy’s Research Centres across the UK are still hard at work, supporting women and families in our specialist clinics and sharing their latest studies with academic journals.

  • Blog

    Miscarriage during lockdown

    The day before Mother’s Day, and two days before the UK officially went into coronavirus lockdown, Zara Dawson found out she was having a miscarriage. Her third consecutive miscarriage in less than a year, and fourth consecutive loss, after losing her second son Jesse in 2018 to termination for medical reasons.

    Was this information useful?

    Yes No